2002
Berk JL, O’Regan A, Skinner M
Pulmonary and tracheobronchial amyloidosis. Seminars in Respiratory and Critical Care Medicine, 23: 155-165, 2002.
Lim A, Prokaeva T, Connors LH, Falk RH, Skinner M, Costello CE
Identification of a novel transthyretin Thr59Lys/Arg104His: a case of compound heterozygosity in a Chinese patient diagnosed with familial transthyretin amyloidosis. Amyloid: J Protein Folding Disorders, 9: 134-140, 2002.
Lim A, Prokaeva T, McComb ME, O’Connor PB, Theberge R, Connors LH, Skinner M, Costello CE
Characterization of transthyretin variants in familial transthyretin amyloidosis by mass spectrometric peptide mapping and DNA sequence analysis. Anal Chem. 74: 741-751, 2002.
Sanchorawala V, Wright DG, Seldin DC, Falk RH, Berk JL, Dember LM, Finn KT, Skinner M (PDF)
Low dose continuous oral melphalan for the treatment of primary systemic (AL) amyloidosis. Brit J Hematology, 117: 886-890, 2002.
Seldin DC
AL amyloidosis: A curable disease? editorial in: Amyloid: J Protein Folding Disorders, 9:203-6, 2002.
Sipe JD, Merlini G, Skinner M, Westermark P, Benson M, Kisilevsky R, Bely M
Meeting Report: IX International Symposium on Amyloidosis, July 15-21, Budapest, Hungary. Amyloid: The Journal of Protein Folding Disorders, 9: 52-65, 2002.
Yazaki M, Connors LH, Eagle RC, Leff SR, Skinner M, Benson MD
Transthyretin amyloidosis associated with a novel variant (Trp41Leu) presenting with vitreous opacities. Amyloid: J Prot Folding Disorders, 9: 263-267, 2002.
Zerbini CAF, Anderson JJ, Kane KA, Ju S-T, Campistol JM, Simms RW, Cohen AS, Skinner M
2 microglobulin serum levels and prediction of survival in AL amyloidosis. Amyloid: J Prot Folding Disorders, 9: 242-246, 2002.
|
